173 related articles for article (PubMed ID: 24958442)
1. Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (¹³¹I-GMSs) following intratumoral injection.
Li CC; Chi JL; Ma Y; Li JH; Xia CQ; Li L; Chen Z; Chen XL
Radiat Oncol; 2014 Jun; 9():144. PubMed ID: 24958442
[TBL] [Abstract][Full Text] [Related]
2. Effect of (131)I gelatin microspheres on hepatocellular carcinoma in nude mice and its distribution after intratumoral injection.
Chi JL; Li CC; Xia CQ; Li L; Ma Y; Li JH; Chen Z; Chen XL
Radiat Res; 2014 Apr; 181(4):416-24. PubMed ID: 24720750
[TBL] [Abstract][Full Text] [Related]
3. Direct in vivo injection of 131I-GMS and its distribution and excretion in rabbit.
Ma Y; Wan Y; Luo DH; Duan LG; Li L; Xia CQ; Chen XL
World J Gastroenterol; 2010 May; 16(17):2120-8. PubMed ID: 20440852
[TBL] [Abstract][Full Text] [Related]
4. In vivo distribution of (131)I and (125)I dual-labeled gelatin microspheres after implantation into rabbit liver.
Ma Y; Li B; Li L; Duan LG; Wei YG; Chen XL
Cancer Biother Radiopharm; 2012 May; 27(4):267-75. PubMed ID: 22489662
[TBL] [Abstract][Full Text] [Related]
5. [Experimental study of bio-distribution and tumor imaging of 131I in nude mice bearing human breast cancer].
Fan W; Wang GH; Yang MT; Zhang WG; Dai JJ; Yang XC
Ai Zheng; 2004 Jul; 23(7):808-11. PubMed ID: 15248917
[TBL] [Abstract][Full Text] [Related]
6. 131I-recombinant human EGF has antitumor effects against MCF-7 human breast cancer xenografts with low levels of EGFR.
Li YC; Xu WY; Tan TZ; He S
Nucl Med Biol; 2004 May; 31(4):435-40. PubMed ID: 15093813
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution of 131I-BSA loaded gelatin microspheres after peroral application to BALB/c mice--particle size study.
Mladenovska K; Janevik EI; Glavas MD; Kumbaradzi EF; Goracinova K
Acta Pharm; 2003 Sep; 53(3):187-97. PubMed ID: 14769242
[TBL] [Abstract][Full Text] [Related]
8. Brachytherapy with Intratumoral Injections of Radiometal-Labeled Polymers That Thermoresponsively Self-Aggregate in Tumor Tissues.
Sano K; Kanada Y; Kanazaki K; Ding N; Ono M; Saji H
J Nucl Med; 2017 Sep; 58(9):1380-1385. PubMed ID: 28408533
[TBL] [Abstract][Full Text] [Related]
9. [Experimental research into the inhibitory effect of 131I-recombinant human epidermal growth factor on the growth of breast cancer in vivo].
Li Y; Xu W; Tan T; He S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):444-8. PubMed ID: 15250153
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and application of 131I-fulvestrant as a targeted radiation drug for endocrine therapy in human breast cancer.
Yin G; Zeng B; Peng Z; Liu Y; Sun L; Liu C
Oncol Rep; 2018 Mar; 39(3):1215-1226. PubMed ID: 29328488
[TBL] [Abstract][Full Text] [Related]
11. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.
Tjuvajev JG; Chen SH; Joshi A; Joshi R; Guo ZS; Balatoni J; Ballon D; Koutcher J; Finn R; Woo SL; Blasberg RG
Cancer Res; 1999 Oct; 59(20):5186-93. PubMed ID: 10537296
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution studies of BSA loaded gelatin microspheres after peroral application.
Mladenovska K; Janevik I; Glavas D; Kumbaradzi F; Goracinova K
Int J Pharm; 2002 Aug; 242(1-2):251-3. PubMed ID: 12176257
[TBL] [Abstract][Full Text] [Related]
13. Prolonged local persistence of cisplatin-loaded gelatin microspheres and their chemoembolic anti-cancer effect in rabbits.
Ohta S; Nitta N; Sonoda A; Seko A; Tanaka T; Takahashi M; Takemura S; Tabata Y; Murata K
Eur J Radiol; 2009 Dec; 72(3):534-40. PubMed ID: 18778907
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of SPECT imaging with 131I-labeled monoclonal antibody SZ39 in nude mice bearing human glioma xenografts.
Lan Q; Huang Q; Bao S
J Neuroimaging; 1996 Apr; 6(2):131-5. PubMed ID: 8634489
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial.
Macey DJ; Grant EJ; Kasi L; Rosenblum MG; Zhang HZ; Katz RL; Rieger PT; LeBherz D; South M; Greiner JW; Schlom J; Podoloff DA; Murray JL
Clin Cancer Res; 1997 Sep; 3(9):1547-55. PubMed ID: 9815842
[TBL] [Abstract][Full Text] [Related]
17. Implantable porous gelatin microspheres sustained release of bFGF and improved its neuroprotective effect on rats after spinal cord injury.
Lan L; Tian FR; ZhuGe DL; ZhuGe QC; Shen BX; Jin BH; Huang JP; Wu MZ; Fan LX; Zhao YZ; Xu HL
PLoS One; 2017; 12(3):e0173814. PubMed ID: 28291798
[TBL] [Abstract][Full Text] [Related]
18. Superparamagnetic iron oxide nanoparticles mediated (131)I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice.
Chen J; Zhu S; Tong L; Li J; Chen F; Han Y; Zhao M; Xiong W
BMC Cancer; 2014 Feb; 14():114. PubMed ID: 24555445
[TBL] [Abstract][Full Text] [Related]
19. Improved effect of 131I-MIBG treatment by predosing with non-radiolabeled MIBG in carcinoid patients, and studies in xenografted mice.
Taal BG; Hoefnagel C; Boot H; Valdés Olmos R; Rutgers M
Ann Oncol; 2000 Nov; 11(11):1437-43. PubMed ID: 11142484
[TBL] [Abstract][Full Text] [Related]
20. [Radiobiological effect of 131I radiolabeled recombinant human epidermal growth factor on nude mice with human breast cancer].
Li Y; Xu W; Tan T; He S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Aug; 22(4):749-53. PubMed ID: 16156265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
